Tarsus Pharmaceuticals(TARS) - 2025 Q4 - Earnings Call Presentation

Building the Future of Eye Care Q4 & Full Year 2025 Financial Results February 2026 Vivian, an XDEMVY patient. World-Class Leadership Team With Proven Track Record of Success 2 | © Tarsus Pharmaceuticals | For Investor Purposes Only Bobby Azamian, MD, PhD CEO & Chairman Aziz Mottiwala Chief Commercial Officer Sesha Neervannan, PhD Chief Operating Officer Jeff Farrow Chief Financial & Strategy Officer Forward-looking Statements This presentation contains forward-looking statements that involve risks and unce ...